266 related articles for article (PubMed ID: 32992138)
1. The p53-inducible CLDN7 regulates colorectal tumorigenesis and has prognostic significance.
Hou Y; Hou L; Liang Y; Zhang Q; Hong X; Wang Y; Huang X; Zhong T; Pang W; Xu C; Zhu L; Li L; Fang J; Meng X
Neoplasia; 2020 Nov; 22(11):590-603. PubMed ID: 32992138
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of CLDN7 due to promoter hypermethylation is associated with human clear cell renal cell carcinoma progression and poor prognosis.
Li Y; Gong Y; Ning X; Peng D; Liu L; He S; Gong K; Zhang C; Li X; Zhou L
J Exp Clin Cancer Res; 2018 Nov; 37(1):276. PubMed ID: 30428910
[TBL] [Abstract][Full Text] [Related]
3. LUCAT1 promotes colorectal cancer tumorigenesis by targeting the ribosomal protein L40-MDM2-p53 pathway through binding with UBA52.
Zhou Q; Hou Z; Zuo S; Zhou X; Feng Y; Sun Y; Yuan X
Cancer Sci; 2019 Apr; 110(4):1194-1207. PubMed ID: 30690837
[TBL] [Abstract][Full Text] [Related]
4. Claudin-7 deficiency promotes stemness properties in colorectal cancer through Sox9-mediated Wnt/β-catenin signalling.
Xu C; Ding YH; Wang K; Hao M; Li H; Ding L
J Transl Med; 2021 Jul; 19(1):311. PubMed ID: 34281572
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA DDX11-AS1 induced by YY1 accelerates colorectal cancer progression through targeting miR-873/CLDN7 axis.
Tian JB; Cao L; Dong GL
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5714-5729. PubMed ID: 31298324
[TBL] [Abstract][Full Text] [Related]
6. Dysregulation of Claudin family genes in colorectal cancer in a Chinese population.
Tang W; Dou T; Zhong M; Wu Z
Biofactors; 2011; 37(1):65-73. PubMed ID: 21294205
[TBL] [Abstract][Full Text] [Related]
7. Tumour-promoting role of SOCS1 in colorectal cancer cells.
Tobelaim WS; Beaurivage C; Champagne A; Pomerleau V; Simoneau A; Chababi W; Yeganeh M; Thibault P; Klinck R; Carrier JC; Ferbeyre G; Ilangumaran S; Saucier C
Sci Rep; 2015 Sep; 5():14301. PubMed ID: 26391193
[TBL] [Abstract][Full Text] [Related]
8. microRNA-1827 represses MDM2 to positively regulate tumor suppressor p53 and suppress tumorigenesis.
Zhang C; Liu J; Tan C; Yue X; Zhao Y; Peng J; Wang X; Laddha SV; Chan CS; Zheng S; Hu W; Feng Z
Oncotarget; 2016 Feb; 7(8):8783-96. PubMed ID: 26840028
[TBL] [Abstract][Full Text] [Related]
9. CircMYH9 drives colorectal cancer growth by regulating serine metabolism and redox homeostasis in a p53-dependent manner.
Liu X; Liu Y; Liu Z; Lin C; Meng F; Xu L; Zhang X; Zhang C; Zhang P; Gong S; Wu N; Ren Z; Song J; Zhang Y
Mol Cancer; 2021 Sep; 20(1):114. PubMed ID: 34496888
[TBL] [Abstract][Full Text] [Related]
10. High expression of fibronectin is associated with poor prognosis, cell proliferation and malignancy via the NF-κB/p53-apoptosis signaling pathway in colorectal cancer.
Yi W; Xiao E; Ding R; Luo P; Yang Y
Oncol Rep; 2016 Dec; 36(6):3145-3153. PubMed ID: 27748871
[TBL] [Abstract][Full Text] [Related]
11. Identification of Genes Related to Clinicopathological Characteristics and Prognosis of Patients with Colorectal Cancer.
Gao X; Yang J
DNA Cell Biol; 2020 Apr; 39(4):690-699. PubMed ID: 32027181
[TBL] [Abstract][Full Text] [Related]
12. SPON2, a newly identified target gene of MACC1, drives colorectal cancer metastasis in mice and is prognostic for colorectal cancer patient survival.
Schmid F; Wang Q; Huska MR; Andrade-Navarro MA; Lemm M; Fichtner I; Dahlmann M; Kobelt D; Walther W; Smith J; Schlag PM; Stein U
Oncogene; 2016 Nov; 35(46):5942-5952. PubMed ID: 26686083
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of CPT2 promotes proliferation and inhibits apoptosis through p53 pathway in colorectal cancer.
Liu F; Li X; Yan H; Wu J; Yang Y; He J; Chen J; Jiang Z; Wu F; Jiang Z
Cell Signal; 2022 Apr; 92():110267. PubMed ID: 35108639
[TBL] [Abstract][Full Text] [Related]
14. LACTB, a novel epigenetic silenced tumor suppressor, inhibits colorectal cancer progression by attenuating MDM2-mediated p53 ubiquitination and degradation.
Zeng K; Chen X; Hu X; Liu X; Xu T; Sun H; Pan Y; He B; Wang S
Oncogene; 2018 Oct; 37(41):5534-5551. PubMed ID: 29899406
[TBL] [Abstract][Full Text] [Related]
15. Analysis of potential genes and pathways associated with the colorectal normal mucosa-adenoma-carcinoma sequence.
Wu Z; Liu Z; Ge W; Shou J; You L; Pan H; Han W
Cancer Med; 2018 Jun; 7(6):2555-2566. PubMed ID: 29659199
[TBL] [Abstract][Full Text] [Related]
16.
Peng L; Chang J; Liu X; Lu S; Ren H; Zhou X; Liu Z; Hu P
Curr Issues Mol Biol; 2021 Oct; 43(3):1529-1547. PubMed ID: 34698109
[TBL] [Abstract][Full Text] [Related]
17. FOXD3, frequently methylated in colorectal cancer, acts as a tumor suppressor and induces tumor cell apoptosis under ER stress via p53.
Xu M; Zhu J; Liu S; Wang C; Shi Q; Kuang Y; Fang X; Hu X
Carcinogenesis; 2020 Sep; 41(9):1253-1262. PubMed ID: 31784734
[TBL] [Abstract][Full Text] [Related]
18. TRIM23 overexpression is a poor prognostic factor and contributes to carcinogenesis in colorectal cancer.
Han Y; Tan Y; Zhao Y; Zhang Y; He X; Yu L; Jiang H; Lu H; Tian H
J Cell Mol Med; 2020 May; 24(10):5491-5500. PubMed ID: 32227572
[TBL] [Abstract][Full Text] [Related]
19. Long Non-Coding RNA Reprogramming (ROR) Promotes Cell Proliferation in Colorectal Cancer via Affecting P53.
Li H; Jiang X; Niu X
Med Sci Monit; 2017 Feb; 23():919-928. PubMed ID: 28216611
[TBL] [Abstract][Full Text] [Related]
20. Elevated OCT1 participates in colon tumorigenesis and independently predicts poor prognoses of colorectal cancer patients.
Wang YP; Song GH; Chen J; Xiao C; Li C; Zhong L; Sun X; Wang ZW; Deng GL; Yu FD; Xue YM; Tang HM; Peng ZH; Wang XL
Tumour Biol; 2016 Mar; 37(3):3247-55. PubMed ID: 26433389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]